This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Erfurth Jennifer who is VP, Global HR at Align Technology sold 3,144 shares at $55.34 on Feb. 11, 2014. Following this transaction, the VP, Global HR owned 0 shares meaning that the stake was reduced by 100% with the 3,144-share transaction.

The shares most recently traded at $54.93, down $0.41, or 0.74% since the insider transaction. Historical insider transactions for Align Technology go as follows:

4-Week # shares sold: 32,692

12-Week # shares sold: 38,692

24-Week # shares sold: 4.7 million

The average volume for Align Technology has been 1.2 million shares per day over the past 30 days. Align Technology has a market cap of $4.4 billion and is part of the health care sector and health services industry. Shares are down 3.41% year-to-date as of the close of trading on Tuesday.

Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. The company has a P/E ratio of 70.5. Currently there are 5 analysts that rate Align Technology a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Quant Ratings rates Align Technology as a
buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full
Align Technology Ratings Report from
TheStreet Quant Ratings now.